Jianfeng Group announced that the subsidiary obtained the “Drug Supplement Application Approval Notice” for injectable cefmetoxime hydrochloride, indicating that the drug has passed the consistent evaluation of generic drug quality and efficacy.
尖峰集团：子公司获得注射用盐酸头孢甲肟药品补充申请批准通知书
Jianfeng Group: The subsidiary received a notice of approval for a supplementary application for injectable cefmetoxime hydrochloride drugs
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.